KRISTIN SHANNON: Open Payments
NPI 1013364926 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$919 in 40 payments from 13 companies in 2025. Trend: 2023 $1,417 · 2024 $1,447 · 2025 $919
Food & beverage: $919
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $234 |
| ABBVIE INC. | 5 | $121 |
| PFIZER INC. | 5 | $117 |
| Gilead Sciences, Inc. | 3 | $91 |
| Otsuka America Pharmaceutical, Inc. | 4 | $88 |
| ViiV Healthcare Company | 3 | $59 |
| Lilly USA, LLC | 2 | $50 |
| Lundbeck LLC | 2 | $38 |
| Axsome Therapeutics, Inc. | 1 | $31 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
Products named: REXULTI, VRAYLAR, Wegovy, Ozempic, PREVNAR 20, Rybelsus, NURTEC ODT, APRETUDE.
Industry payments across IL — which companies pay providers there.
